Wolfe Research initiated coverage of Bristol Myers (BMY) with a Peer Perform rating. The firm said there maybe a comeback story with Bristol, ...

Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

If you’re on the fence about investing in Bristol-Myers Squibb Co or Novo Nordisk A/S (ADR) because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

Bristol-Myers Squibb Co.’s stock rose 2.9% early Thursday, after the drug company posted better-than-expected third-quarter earnings and raised its guidance. Princeton, N.J.-based Bristol Myers ...

(RTTNews) - Bristol-Myers Squibb Co. (BMY) announced earnings for third quarter that decreased from last year but beat the Street estimates. The company's earnings came in at $1.211 billion ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Bristol Myers Squibb recently achieved several important clinical and ... include the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received two or more ...

If you’re on the fence about investing in AbbVie Inc or Bristol-Myers Squibb Co because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision ...